IIPTA blogs

Yahoo to End the Facebook Lawsuit As Soon As Possible

harsharohatgi — Mon, 14 May 2012 11:22:12 +0000

BLOCKBUSTER DRUG MARKET SMASHED BY GENERIC VERSIONS: RESULT OF PATENT EXPIRATION

harsharohatgi — Sat, 12 May 2012 10:16:38 +0000

How Indian Celebrities are protected by IP Laws?

MOLIKA GUPTA — Sat, 12 May 2012 10:16:38 +0000

Protecting Celebrity rights under IP laws is a significant development in the field of IPR.

Grant Of First Compulsory License. - Relief for Cancer patients Or Worries for Indian Government?

MOLIKA GUPTA — Sat, 12 May 2012 08:07:43 +0000

Chain Reaction : Major Drug Makers cuts price of Cancer Drugs:

Just a day after German Giant –Bayer Corp. filed an appeal with IPAB against the grant of C.L . to Indian generic company NATCO Pharma Ltd print media were occupied with the headlines that Swiss based Roche Holding AG & local drug maker Cipla Ltd have decided to sharply cut prices of five of their high cost oncology brands.

Battle between Indian Companies and Global Giants in Pharmaceutical Sector

harsharohatgi — Wed, 09 May 2012 13:19:30 +0000

The ultra powerful pharmaceutical multi nationals are facing a setback due to India’s weak patent regime for medicines. India has been favoring the low cost Indian generic companies. Also, recently the Indian patent office granted compulsory license allowing Natco Pharma Ltd to make and sell a copy of German drug maker Bayer AG’s patented cancer treatment Nexavar. The decision to allow Natco Pharma to sell Bayer’s patented cancer drug Nexaver has divided the pharmaceutical industry with domestic firms welcoming the decision while multinationals were disappointed by this decision.

Infosys growing patent portfolio

harsharohatgi — Wed, 09 May 2012 12:56:15 +0000

INDIAN IT COMPANIES FINALLY REALIZING THE IMPORTANCE OF PATENT FILLING

Compulsory License Order Challenged: Bayer Corp. Filed An Appeal against Nexavar

MOLIKA GUPTA — Wed, 09 May 2012 10:09:27 +0000

Patent is an exclusive right granted by the government to an inventor for a limited period of time in exchange of complete disclosure of invention. Compulsory License is an important provision under the amended Indian Patent Act which is used by Indian Patent Office to put a check on the abuse of monopoly provided by the grant of patents to the inventor.

Aamir Khan’s Debutant TV Show in Controversy: Allegations for Infringement of Copyright

MOLIKA GUPTA — Mon, 07 May 2012 12:09:50 +0000

The Controversy:

Indian Pharma Companies an Emerging Generic Player

poonam.singh — Tue, 01 May 2012 04:36:00 +0000

The Indian Pharma Companies has emerged as a strong generic player since the Indian Patent Act has been introduced in 1970. Earlier only process patents are allowed but from 2005 onwards India has shifted towards the product patent regime which has put the industry on a new growth trajectory. There are immense opportunities for Indian generics firms in regions, such as the US, Europe, Japan, and Africa.

Patent Infringement Battle: Yahoo vs Facebook

poonam.singh — Mon, 30 Apr 2012 06:12:21 +0000

Yahoo! Inc. is an American multinational internet corporation headquartered in Sunnyvale, California, United States. It is one of the largest websites in the United States. Since 1994 Yahoo! has grown to become a premiere digital media and communications company. With time Yahoo! Has diversified its product offerings beyond its original directory of websites. For example: Yahoo! has launched My Yahoo! Page which allows users to combine their favorite Yahoo content feed into single page. Yahoo! Has also began web hosting through Yahoo!